Harold A. Kessler

Immunologic Responses Associated with 12 Weeks of Combination Antiretroviral Therapy Consisting of Zidovudine, Lamivudine, and Ritonavir: Results of AIDS Clinical Trials Group Protocol 315

Michael M. Lederman, Elizabeth Connick, Alan Landay et al. · The Journal of Infectious Diseases · 1998 · 428 citations · Full text

Life Sciences, Immunology, Pharmacology +17

A Controlled Trial Comparing Foscarnet with Vidarabine for Acyclovir-Resistant Mucocutaneous Herpes Simplex in the Acquired Immunodeficiency Syndrome

Sharon Safrin, Clyde S. Crumpacker, P A Chatis et al. · New England Journal of Medicine · 1991 · 375 citations · Full text

Medicine, Infectious Diseases, Pharmacology +13

ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids.

Lígia A. Pinto, Jonathan Sullivan, Jay A. Berzofsky et al. · Journal of Clinical Investigation · 1995 · 250 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results

Robert L. Murphy, Scott Brun, Charles B. Hicks et al. · AIDS · 2001 · 239 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Limited immune restoration after 3 years’ suppression of HIV-1 replication in patients with moderately advanced disease

Hernán Valdez, Elizabeth Connick, Kimberly Y. Smith et al. · AIDS · 2002 · 210 citations

Life Sciences, Immunology, Clinical Immunology +11